Showing results (301-310 of 448) with videos related to
Sort By:
Pageof 45
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 1, 1994
Folate receptor of human mammary adenocarcinomaJ Holm, S I Hansen, M Høier-Madsen, et al.Archives of Biochemistry and Biophysics|October 15, 1983
Dependence of aggregation and ligand affinity on the concentration of the folate-binding protein from cow's milkS I Hansen, J Holm, J Lyngbye, et al.AJNR. American Journal of Neuroradiology|April 11, 2015
How Does the Accuracy of Intracranial Volume Measurements Affect Normalized Brain Volumes? Sample Size Estimates Based on 966 Subjects from the HUNT MRI CohortT I Hansen, V Brezova, L Eikenes, et al.Neurogastroenterology and Motility|June 18, 2010
A new distensibility technique to measure sphincter of Oddi functionP Kunwald, A M Drewes, D Kjaer, et al.Cell|May 21, 2019
SCAF4 and SCAF8, mRNA Anti-Terminator ProteinsLea H Gregersen, Richard Mitter, Alejandro P Ugalde, et al.Surgery Open Digestive Advance|February 5, 2024
Fecobionics in proctology: review and perspectivesH Gregersen, D Sun, F Field, et al.Biochimica Et Biophysica Acta|December 31, 2013
The interrelationship between ligand binding and thermal unfolding of the folate binding protein. The role of self-association and pHJan Holm, Linnea N Babol, Natalia Markova, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1995
A high-affinity soluble folate receptor in fluids of non-neoplastic ovarian cysts: radioligand binding, molecular size, hydrophobic residue, and immunological propertiesJ Holm, S I Hansen, M Høier-Madsen, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 1, 1995
Folate receptor in malignant effusions of ovarian carcinomaJ Holm, S I Hansen, M Høier-Madsen, et al.Archives of Biochemistry and Biophysics|June 5, 1999
High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivityJ Holm, S I Hansen, M Høier-Madsen, et al.Pageof 45